{"transactions":[{"id":1207517,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2025-03-13T20:06:04.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":780008,"derivative":{"exercise_price":3.58,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-038717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000095017025038717/ownership.xml","form_type":"4"}},{"id":1588862,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2024-03-07T23:40:03.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":205008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person."}],"balance_after":630008,"derivative":{"exercise_price":3.51,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":205008},"source":{"system":"sec-edgar","filing":"0001628280-24-009747","document":"wk-form4_1709854793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024009747/wk-form4_1709854793.xml","form_type":"4"}},{"id":3397264,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-05T00:36:06.000Z","date":"2019-10-04","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019."}],"balance_after":20000,"derivative":{"exercise_price":0.6391,"expiration_date":"2029-10-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-052621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919119052621/doc4.xml","form_type":"4"}},{"id":3553592,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":82018,"kind":"person","name":"Kabbinavar Fairooz","position":1,"cik":"0001774182","reported_name":"Kabbinavar Fairooz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-17T20:24:08.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after 4/15/2019; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/15/2019."}],"balance_after":100000,"derivative":{"exercise_price":9.94,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-024982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919119024982/doc4.xml","form_type":"4"}}]}